This inventor holds 2 USPTO granted patents and 1 published patent application. Top assignees: Dr. Falk Pharma Gmbh, The University of Edinburgh. Active years: 2022-2025.
Company Filing History:
Years Active: 2022-2025
Title: The Innovations of Anne Louise Walker
Introduction
Anne Louise Walker is a notable inventor based in Stevenage, GB. She has made significant contributions to the field of medicinal chemistry, particularly in the development of compounds that target various disorders. With a total of 2 patents, her work has the potential to impact the treatment of several serious health conditions.
Latest Patents
Walker’s latest patents include the development of 3-(5-chloro-2-oxobenzo[d]oxazol-3(2H)-yl) propanoic acid derivatives as KMO inhibitors. These compounds are designed to treat disorders mediated by KMO, such as acute pancreatitis, chronic kidney disease, and various neurodegenerative diseases including Huntington's disease and Alzheimer's disease. The compounds are also useful in addressing conditions associated with systemic inflammatory response syndrome (SIRS), Parkinson's disease, and severe trauma, among others.
Career Highlights
Throughout her career, Anne Louise Walker has worked with esteemed institutions such as the University of Edinburgh and Dr. Falk Pharma GmbH. Her research has focused on innovative solutions to complex medical challenges, showcasing her dedication to advancing healthcare through scientific discovery.
Collaborations
Some of her notable coworkers include Anne Marie Jeanne Bouillot and Olivier Mirguet. Their collaborative efforts have contributed to the success of her research initiatives.
Conclusion
Anne Louise Walker's contributions to medicinal chemistry and her innovative patents highlight her role as a significant figure in the field. Her work continues to pave the way for advancements in the treatment of various health disorders.